Showing 1,761 - 1,780 results of 3,158 for search 'Patient Number 9', query time: 0.07s Refine Results
  1. 1761

    Assessment of Silicone Oil Emulsification: A Comparison of Currently Applied Methods by Hongmei Zhao, Qian Chen, Jian Yu, Kaicheng Wu, Yuan Zong, Chunhui Jiang, Haohao Zhu, Gezhi Xu

    Published 2023-01-01
    “…The mean UBM grading was 26.41 ± 9.71 (range: 1–36); the mean SO index obtained with B-scan was 5.25 ± 5.00% (range: 0.10–16.49%), and the mean number of SO droplets was 1.26 ± 2.45 × 107/mL and 3.34 ± 4.22 × 106/mL in the first and last 2 mL of washout fluid, respectively. …”
    Get full text
    Article
  2. 1762

    Analysis of Publications on Psoriasis and Tuberculosis by Sevil Alkan, İrem Şahinoğlu, Mustafa Serhat Şahinoğlu

    Published 2024-02-01
    “…The United States (n=26), Italy (n=21), Spain (n=12) were the first 3 countries in the number of publications. The most of the articles were from Dermatology (n=93, 73%) and Rheumatology (n=11, 9%) research areas. …”
    Get full text
    Article
  3. 1763
  4. 1764

    Hubungan Jumlah Komplikasi Kronik Dengan Derajat Gejala Depresi Pada Pasien Diabetes Melitus Tipe 2 Di Poliklinik Rsup Dr. M. Djamil Padang by Try Rahmi Lussii Karsuita, Eva Decroli, Delmi Sulastri

    Published 2016-09-01
    “…The objective of this study was to reveal the difference of the number of chronic complications on every single degree of depression in patients with type 2 diabetes. …”
    Get full text
    Article
  5. 1765
  6. 1766
  7. 1767

    Effect of ripasudil after trabeculectomy with mitomycin C: a multicentre, randomised, prospective clinical study by Kazuyuki Hirooka, Eri Nitta, Yoshiaki Kiuchi, Masaki Tanito, Shunsuke Nakakura, Tetsuya Baba, Hideaki Okumichi, Aisyah Muhlisah, Ariyanie Nurtania, Hiromitsu Onoe, Yotaro Matsuoka

    Published 2024-05-01
    “…At baseline, the mean IOP was 16.8±5.0 mm Hg in the ripasudil group (38 patients) and 16.2±4.4 in the non-ripasudil group (52 patients). …”
    Get full text
    Article
  8. 1768
  9. 1769

    Potentially Preventable Deaths by Intensive Care Medicine in Mongolian Hospitals by Naranpurev Mendsaikhan, Tsolmon Begzjav, Ganbold Lundeg, Martin W. Dünser

    Published 2016-01-01
    “…Results. 617 patients died (72.9% in and 27.1% outside the ICU) during the observation period. …”
    Get full text
    Article
  10. 1770

    Hubungan Jumlah Komplikasi Kronik Dengan Derajat Gejala Depresi Pada Pasien Diabetes Melitus Tipe 2 Di Poliklinik Rsup Dr. M. Djamil Padang by Try Rahmi Lussii Karsuita, Eva Decroli, Delmi Sulastri

    Published 2016-09-01
    “…The objective of  this  study was to reveal the difference of the number of chronic complications on every single degree of depression in patients with type 2 diabetes. …”
    Get full text
    Article
  11. 1771

    Spot Versus 24-Hour Urine Osmolality Measurement in Autosomal Dominant Polycystic Kidney Disease: A Diagnostic Test Study by Ayub Akbari, Sriram Sriperumbuduri, Shreepryia Mangalgi, Vijay Joshi, Manish Sood, Amos Buh, Mohan Biyani, Christopher McCudden, Gregory L. Hundemer, Pierre Antoine Brown

    Published 2025-03-01
    “…The study was conducted at a single center. Limited number of patients were on tolvaptan. Conclusions: In adults with ADPKD, important differences exist between the 24-hour urine osmolality and spot urine osmolality that preclude interchangeable use. …”
    Get full text
    Article
  12. 1772

    Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study by Mohammed Hasosah, Ghassan Sukkar, Asharf AlSahafi, Ali Zaidan, Nouf Ghous, Abdulmajed Alshahrani, Ziyad Al Zahrani, Naif Hasosah, Mansour Qurashi, Loie Goronfolah, Ali Alsharief, Nagla Kamal

    Published 2025-02-01
    “…In addition to the improvement in EoE, the use of corticosteroids in EoE and inhaled corticosteroids in asthma was decreased for all patients, suggesting that dupilumab may be effective in patients with multiple concurrent atopic conditions. …”
    Get full text
    Article
  13. 1773

    Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma by Yuan Yao, Yiyi Yan, Vera J. Suman, Allan B. Dietz, Courtney L. Erskine, Anastasios Dimou, Svetomir N. Markovic, Svetomir N. Markovic, Robert R. McWilliams, Heather N. Montane, Matthew S. Block, Matthew S. Block

    Published 2025-02-01
    “…Blood samples were collected after each cycle of treatment for immunophenotyping and Th1/Th2 polarity assessment based on immune response markers.ResultsBetween January 31, 2017 and January 9, 2023, 17 patients were enrolled. The MTD of ibrutinib in combination with pembrolizumab was determined to be 420 mg daily. …”
    Get full text
    Article
  14. 1774
  15. 1775
  16. 1776

    Global comparison of the economic costs of coronary heart disease: a systematic review and meta-analysis by Lan Gao, Susan Brumby, Crystal Man Ying Lee, George Mnatzaganian, Suzanne Robinson, Helen Brown, Rachel Huxley, Anna Peeters, Dan Xu, James Boyd, Sean Randall, Adrienne O’Neil, Sangita Shakya, Sarah Gauci, Anita Shrestha, James Lucas

    Published 2025-01-01
    “…The pooled direct annual cost of CHD per patient varied from 4.9% to 137.8% of GDP per capita (Int$ purchasing power parity), with pooled percentage of 21.7% (95% CI 15.3, 28.1) for those with CHD. …”
    Get full text
    Article
  17. 1777
  18. 1778
  19. 1779
  20. 1780